NNM Securities

COMPANY
more from company profile
HomeMarket Info Company Profile Smart Quotes

Smart Quotes

ASTRAZENECA PHARMA INDIA LTD.

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC
BSE3475.0036.85 (+1.07 %)
PREV CLOSE ( ) 3438.15
OPEN PRICE ( ) 3442.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4199
TODAY'S LOW / HIGH ( )3441.00 3594.00
52 WK LOW / HIGH ( )1888 4970
NSE3455.8519.6 (+0.57 %)
PREV CLOSE( ) 3436.25
OPEN PRICE ( ) 3472.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 3455.85 (25)
VOLUME 22117
TODAY'S LOW / HIGH( ) 3440.15 3500.00
52 WK LOW / HIGH ( )1885 4970
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 11-07 1979
Management Info
Narayan K Seshadri - Chairman Gagandeep Singh Bedi - Managing Director
Registered Office

Address Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring Road,
Bengaluru,
Karnataka-560045

Phone

Email comp.secy@astrazeneca.com

Website www.astrazenecaindia.com

Registrars Details
Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
30, Ramana Residency,4th Cross, Sampige Road,Malleswaram,Bangalore
 Listing : BSE, NSE, MCX
NEWS
08Feb Hindustan Aeronautics, Bharat Dynamics
Hindustan Aeronautics (HAL) has signed a memorandum of understanding (Mo..
08Feb AstraZeneca Pharma receives import, ma
AstraZeneca Pharma India has received Import and Market Permission in Fo..
08Feb AstraZeneca Pharma shines on receiving
Astrazeneca Pharma India is currently trading at Rs. 3954.00, up by 58.9..
29Jan Board Meeting Intimation for Meeting
ASTRAZENECA PHARMA INDIA LTD.has informed BSE that the meeting of the Bo..
21Dec AstraZeneca Pharma gets import, market
AstraZeneca Pharma India has received Import and Market Permission in Fo..
MORE
Financials
Rs. in Millions
QTR Dec 20 ANNUAL 20
Net Profit210.52722.1
Gross Profit 283.01 1139.6
Operating Profit 336.711336.81
Net Sales 2002.528318.09
MORE
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Alkem Laboratories (BSE)
 2840.00 (4.47%)
M.Cap (Rs. in Cr)33956.46
Abbott India (BSE)
 14514.15 (0.82%)
M.Cap (Rs. in Cr)30841.56
Divis Lab (BSE)
 3472.00 (3.08%)
M.Cap (Rs. in Cr)92170.69
Pfizer (BSE)
 4630.30 (1.75%)
M.Cap (Rs. in Cr)21182.57
Ipca Laboratories (BSE)
 1914.95 (3.55%)
M.Cap (Rs. in Cr)24291.54
MORE
Shareholding Pattern
PROMOTERS 75%
NON-INSTITUTION 21.18%
MUTUAL FUNDS/UTI 1.37%
FI/BANKS/INSURANCE 0.02%
GOVERNMENT 0%
FII 0%
MORE
Mf Holdings
MORE
ATTENTION INVESTORSKYCIPO
TERMS & CONDITIONS| PRIVACY POLICY| DISCLAIMER| DISCLOSURE| SEBI| FMC| NSE| BSE| MCX | SCORES
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
Assamese Bengali Gujrati Hindi Kanada
Kashmiri Konkani Malyalam Marathi Oriya
Punjabi Sindhi Tamil Telegu Urdu
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016

INVESTOR PROTECTION

Compliance officer : Jerina George, Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075,9768009000, E-mail ID: compliance@nnmsecurities.com,cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.